A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: Two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland

Journal of Medical Genetics

Volumn 35, Issue 6, 1998, Pages 446-449

  Arason, Adalgeir ^a   Jonasdottir, Adalbjörg ^a   Barkardottir, Rosa Björk ^a   Bergthorsson, Jon Thor ^a   Teare, M Dawn ^b   Easton, Douglas F ^b   Egilsson, Valgardur ^a  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

BRCA1; BRCA2; LOH

Indexed keywords

ALLELE; ARTICLE; BREAST CANCER; CHROMOSOME DELETION; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENE MUTATION; GENETIC LINKAGE; GENETIC SCREENING; GENOTYPE; HETEROZYGOSITY LOSS; HETEROZYGOTE; HUMAN; HUMAN TISSUE; ICELAND; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL;

EID: 0031776312     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.35.6.446     Document Type: Article

References (10)

1. Claus EB, Risch N, Thompson D. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 1991;48:232-42.
2. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
3. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378: 789-92.
4. Tavtigian SV, Simard J, Rommens J, et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 1996;12:333-7.
5. Wooster R, Neuhausen SL, Mangion J, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.Sciece 1994;265:2088-90.
6. Easton DF, Ford D, Bishop DT, and the Breast Cancer Linkage Consortium. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 1995;56: 265-71.
7. Narod SA, Ford D, Devilee P, et al, and the Breast Cancer Linkage Consortium. An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Am J Hum Genet 1995;56:254-64.
8. Scully R, Chen J, Plug A, et al. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 1997;88:265-75.
9. Sharan SK, Morimatsu M, Albrecht U, et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking BRCA2. Nature 1997;386:804-10.
10. Smith SA, Easton DF, Evans DG, Ponder BA. Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat Genet 1992;2: 128-31.